SCHEMBL30298043

SCHEMBL30298043

Nc1nc(Cc2cccnc2)nc2[nH]ccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 3/20 0.46
HRH3 Q9Y5N1 3/20 0.46
MMP2 P08253 1/20 0.43
CCNK O75909 1/20 0.40
CDK12 Q9NYV4 1/20 0.40
NUDT1 P36639 1/20 0.40
PNP P00491 1/20 0.39
MPO P05164 1/20 0.39
CYP1A2 P05177 2/20 0.38
CYP2D6 P10635 1/20 0.38
CHRNA7 P36544 1/20 0.37
JAK2 O60674 1/20 0.36
JAK1 P23458 1/20 0.36
TYK2 P29597 1/20 0.36
JAK3 P52333 1/20 0.36
CYP19A1 P11511 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20508793 1.00 HRH4 (0.46) HRH4HRH3MMP2CCNKCDK12
Hydrochloric Acid SCHEMBL30297964 0.99 HRH4 (0.44) HRH4HRH3MMP2CCNKCDK12
SCHEMBL28110985 0.84 CYP1A2 (0.48) HRH4HRH3CYP1A2CYP2D6JAK2
SCHEMBL30297934 0.83 HTR6 (0.40) HRH4HRH3PNPCYP1A2CYP2D6
Hydrochloric Acid SCHEMBL30297929 0.82 HTR6 (0.39) HRH4HRH3PNPCYP1A2CYP2D6
SCHEMBL30298028 0.76 NUDT1 (0.44) NUDT1CYP1A2JAK2JAK1TYK2
Hydrochloric Acid SCHEMBL30297975 0.75 NUDT1 (0.43) NUDT1CYP1A2JAK2JAK1TYK2
SCHEMBL29715845 0.74 APP (0.41) CYP2D6JAK2ADORA2AADORA1
SCHEMBL20508792 0.74 L3MBTL1 (0.41) HRH4HRH3NUDT1PNPJAK2
SCHEMBL20508822 0.74 PDE8B (0.39) HRH4PNPADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4398986-A1 METHODS FOR TREATING NEUROGENERATIVE DISEASES PTC Therapeutics, Inc. (US) 2024-07-17 EP claimed
WO-2023039368-A1 METHODS FOR TREATING NEUROGENERATIVE DISEASES PTC THERAPEUTICS, INC. (US) 2023-03-16 WO claimed